Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half

Restarting antiplatelet therapy after intracranial hemorrhage remains controversial, but new evidence suggests aspirin or clopidogrel can significantly reduce recurrent ICH without increased bleeding.
Medscape Medical News

Source link

Related posts

Four Neurology Studies to Know


Thienopyridine Agents and Patent Foramen Ovale Closures Reduce Migraines


bpod-mrc: Fattening Up On the left, mature human fat cells…


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy